Reproducibility of plasma and urine biomarkers among premenopausal and postmenopausal women from the nurses health studies

Cancer Epidemiology Biomarkers and Prevention

Volumn 19, Issue 4, 2010, Pages 938-946

  Kotsopoulos, Joanne ^a   Tworoger, Shelley S ^a,c   Campos, Hannia ^d   Chung, Fung Lung ^e   Clevenger, Charles V ^f   Franke, Adrian A ^g   Mantzoros, Christos S ^c   Ricchiuti, Vincent ^b   Willett, Walter C ^a,c,d   Hankinson, Susan E ^a,c   Eliassen, A Heather ^a  

^a CHANNING LABORATORY   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^e GEORGETOWN UNIVERSITY   (United States)

^f NORTHWESTERN UNIVERSITY   (United States)

^g UNIVERSITY OF HAWAII CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CAROTENOID; DOPAMINE; FATTY ACID; HYDROCORTISONE; LEPTIN RECEPTOR; MATRIX METALLOPROTEINASE; MELATONIN; PHYTOESTROGEN; RESISTIN; STRESS HORMONE; VITAMIN D;

ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MEDICAL DECISION MAKING; MENOPAUSAL SYNDROME; PREMENSTRUAL SYNDROME; PRIORITY JOURNAL; REPRODUCIBILITY; URINALYSIS;

ADULT; BIOLOGICAL MARKERS; CHROMATOGRAPHY, LIQUID; FEMALE; HUMANS; MIDDLE AGED; NURSES; POSTMENOPAUSE; PREMENOPAUSE; REPRODUCIBILITY OF RESULTS; TANDEM MASS SPECTROMETRY;

EID: 77950832775     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-09-1318     Document Type: Article

References (50)

1. Tworoger SS, Hankinson SE. Use of biomarkers in epidemiologic studies: minimizing the influence of measurement error in the study design and analysis. Cancer Causes Control 2006; 17: 889-899
2. RosnerB,SpiegelmanD,WillettWC. Correctionoflogisticregressionrelativeriskestimatesandconfidenceintervalsforra ndomwithinpersonmeasurementerror.AmJEpidemiol1992;136:1400- 1413(Pubitemid23046425)
3. Hankinson SE, Willett WC, Manson JE, et al. Alcohol, height, and adiposity in relation to estrogen and prolactin levels in postmenopausal women. J Natl Cancer Inst 1995; 87: 1297-1302
4. SchernhammerES,RosnerB,WillettWC,etal. Epidemiologyofurinarymelatonininwomenanditsrelation-otherhormonesandnightwork. CancerEpidemiolBiomarkersPrev2004;13:936-943(Pubitemid38756703)
5. Missmer SA, Spiegelman D, Bertone-Johnson ER, et al. Reproducibility of plasma steroid hormones, prolactin, and insulin-like growth factor levels among premenopausal women over a 2- to 3-year period. Cancer Epidemiol Biomarkers Prev 2006; 15: 972-978 (Pubitemid 43823526)
6. Eliassen AH, Ziegler RG, Rosner B, et al. Reproducibility of fifteen urinary estrogens and estrogen metabolites over a 2- to 3-year period in premenopausal women. Cancer Epidemiol Biomarkers Prev 2009; 18: 2860-2868
7. Franke AA, Halm BM, Kakazu K, Li X, Custer LJ. Phytoestrogenic isoflavonoids in epidemiologic and clinical research. Drug Testing & Analysis 2009; 1: 14-21.
8. Gout PW, Beer CT, Noble RL. Prolactin-stimulated growth of cell cultures established from malignant Nb rat lymphomas. Cancer Res 1980; 40: 2433-2436
9. Vaughan GM. New sensitive serum melatonin radioimmunoassay employing the Kennaway G280 antibody: Syrian hamster morning adrenergic response. J Pineal Res 1993; 15: 88-103.
10. HollisBW,KamerudJQ,KurkowskiA,BeaulieuJ,NapoliJL. Quantificationofcirculating1,25-dihydroxyvitaminDbyradioimmunoassaywith125I- labeledtracer.ClinChem1996;42:586-592(Pubitemid126423171)
11. Hollis BW, Kamerud JQ, Selvaag SR, Lorenz JD, Napoli JL. Determination of vitamin D status by radioimmunoassay with an 125I-labeled tracer. Clin Chem 1993; 39: 529-533
12. El-SohemyA,BaylinA,KabagambeE,etal. Individualcarotenoidconcentrationsinadiposetissueandplasmaasbiomarkersofd ietaryintake.AmJClinNutr2002;76:172-179(Pubitemid34686563)
13. Chernecky CC, Berger BJ. Laboratory tests and diagnostic procedures. St. Louis: Saunders; 2008.
14. ChungFL,JiaoD,GetahunSM,YuMC. Aurinarybiomarkerforuptakeofdietaryisothiocyanatesinhumans. CancerEpidemiolBiomarkersPrev1998;7:103-108(Pubitemid28109840)
15. Baylin A, Kim MK, Donovan-Palmer A, et al. Fasting whole blood as a biomarker of essential fatty acid intake in epidemiologic studies: comparison with adipose tissue and plasma. Am J Epidemiol 2005; 162: 373-381 (Pubitemid 41389719)
16. Hsu HY, Wittemann S, Joos TO. Miniaturized parallelized sandwich immunoassays. Methods Mol Biol 2008; 428: 247-261
17. Fargnoli J, Sun Q, Olenczuk D, et al. Resistin is associated with biomarkers of inflammation while total and HMW adiponectin are associated with biomarkers of inflammation, insulin resistance, and endothelial function. Eur J Endocrinol 2010; 162: 281-288
18. Shea SA, Hilton MF, Orlova C, Ayers RT, Mantzoros CS. Independent circadian and sleep/wake regulation of adipokines and glucose in humans. J Clin Endocrinol Metab 2005; 90: 2537-2544 (Pubitemid 40686288)
19. RosnerB.PercentagepointsforgeneralizedESDmany-outlierprocedure. Technometrics1983:165-172(Pubitemid13540616)
20. Hankinson SE, Manson JE, Spiegelman D, et al. Reproducibility of plasma hormone levels in postmenopausal women over a 2-3-year period. Cancer Epidemiol Biomarkers Prev 1995; 4: 649-654
21. Rosner B. Fundamentals of biostatistics. Belmont, CA: Duxbury; 2006.
22. Armstrong B, White E, Saracci R. Principles of exposure measurement in epidemiology. Oxford: Oxford University Press; 1992.
23. Willett WC. Nutritional epidemiology monographs in epidemiology and biostatisitcs. Oxford: Oxford University Press; 1998.
24. Adlercreutz H. Phyto-oestrogens and cancer. Lancet Oncol 2002; 3: 364-373
25. Chun OK, Chung SJ, Song WO. Urinary isoflavones and their metabolites validate the dietary isoflavone intakes in US adults. J Am Diet Assoc 2009; 109: 245-254
26. Sonestedt E, Ericson U, Gullberg B, et al. Variation in fasting and non-fasting serum enterolactone concentrations in women of the malmo diet and cancer cohort. Eur J Clin Nutr 2008; 62: 1005-1009
27. Zeleniuch-JacquotteA,AdlercreutzH,AkhmedkhanovA,TonioloP. Reliabilityofserummeasurementsoflignansandisoflavonoidphytoestrogensoveratwo- yearperiod.CancerEpidemiolBiomarkersPrev1998;7:885-889(Pubitemid28471576)
28. Franke AA, Custer LJ, Wilkens LR, et al. Liquid chromatographicphotodiode array mass spectrometric analysis of dietary phytoestrogens from human urine and blood. J Chromatogr B Analyt Technol Biomed Life Sci 2002; 777: 45-59.
29. Al-Delaimy WK, Ferrari P, Slimani N, et al. Plasma carotenoids as biomarkers of intake of fruits and vegetables: individual-level correlations in the European Prospective Investigation into Cancer and Nutrition (EPIC). Eur J Clin Nutr 2005; 59: 1387-1396 (Pubitemid 43135154)
30. Al-Delaimy WK, Natarajan L, Sun X, Rock CL, Pierce JP. Reliability of plasma carotenoid biomarkers and its relation to study power. Epidemiology 2008; 19: 338-344 (Pubitemid 351253025)
31. Comstock GW, Burke AE, Hoffman SC, et al. The repeatability of serum carotenoid, retinoid, and tocopherol concentrations in specimens of blood collected 15 years apart. Cancer Epidemiol Biomarkers Prev 2001; 10: 65-68
32. Laviolle B, Froger-Bompas C, Guillo P, et al. Relative validity and reproducibility of a 14-item semi-quantitative food frequency questionnaire for cardiovascular prevention. Eur J Cardiovasc Prev Rehabil 2005; 12: 587-595
33. Hollis BW. Assessment of vitamin D nutritional and hormonal status: what to measure and how to do it. Calcif Tissue Int 1996; 58: 4-5.
34. Duffy MJ, Maguire TM, Hill A, McDermott E, O'Higgins N. Metalloproteinases: role in breast carcinogenesis, invasion and metastasis. Breast Cancer Res 2000; 2: 252-257 (Pubitemid 32223594)
35. Linkov F, Gu Y, Arslan AA, et al. Reliability of tumor markers, chemokines, and metastasis-related molecules in serum. Eur Cytokine Netw 2009; 20: 21-26
36. HaroLS,LeeDW,SinghRN,etal.Glycosylatedhumanprolactin: alterationsinglycosylationpatternmodifyaffinityforlactogenreceptorandvaluesinpr olactinradioimmunoassay.JClinEndocrinolMetab1990;71:379-383(Pubitemid20261823)
37. Bernichtein S, Jeay S, Vaudry R, Kelly PA, Goffin V. New homologous bioassays for human lactogens show that agonism or antagonism of various analogs is a function of assay sensitivity. Endocrine 2003; 20: 177-190
38. Tworoger SS, Eliassen AH, Rosner B, Sluss P, Hankinson SE. Plasma prolactin concentrations and risk of postmenopausal breast cancer. Cancer Res 2004; 64: 6814-6819 (Pubitemid 39297946)
39. Simeon D, Knutelska M, Smith L, Baker BR, Hollander E. A preliminary study of cortisol and norepinephrine reactivity to psychosocial stress in borderline personality disorder with high and low dissociation. Psychiatry Res 2007; 149: 177-184 (Pubitemid 46108114)
40. Widmer IE, Puder JJ, Konig C, et al. Cortisol response in relation to the severity of stress and illness. J Clin Endocrinol Metab 2005; 90: 4579-4586 (Pubitemid 41159346)
41. Selmaoui B, Touitou Y. Reproducibility of the circadian rhythms of serum cortisol and melatonin in healthy subjects: a study of three different 24-h cycles over six weeks. Life Sci 2003; 73: 3339-3349 (Pubitemid 37311375)
42. Lovallo WR, Farag NH, Vincent AS, Thomas TL, Wilson MF. Cortisol responses to mental stress, exercise, and meals following caffeine intake in men and women. Pharm Biochem Behav 2006; 83: 441-447
43. Arendt J. Melatonin and the pineal gland: influence on mammalian seasonal and circadian physiology. Rev Reprod 1998; 3: 13-22. (Pubitemid 28062305)
44. Graham C, Cook MR, Kavet R, Sastre A, Smith DK. Prediction of nocturnal plasma melatonin from morning urinary measures. J Pineal Res 1998; 24: 230-238 (Pubitemid 28206444)
45. Kripke DF, Youngstedt SD, Elliott JA, et al. Circadian phase in adults of contrasting ages. Chronobiol Int 2005; 22: 695-709.
46. Vineis P. Sources of variation in biomarkers. IARC Sci Publ; 1997. pp. 59-71.
47. RosnerB,HennekensCH,KassEH,MiallWE.Age- specificcorrelationanalysisoflongitudinalbloodpressuredata.AmJEpidemiol1977;106: 306-313(Pubitemid8201848)
48. ShekelleRB,ShryockAM,PaulO,etal.Diet,serumcholesterol, anddeathfromcoronaryheartdisease.TheWesternElectricstudy.NEnglJMed1981;304: 65-70.(Pubitemid11170309)
49. Tworoger SS, Eliassen AH, Sluss P, Hankinson SE. A prospective study of plasma prolactin concentrations and risk of premenopausal and postmenopausal breast cancer. J Clin Oncol 2007; 25: 1482-1488 (Pubitemid 46733075)
50. Hankinson SE, London SJ, Chute CG, et al. Effect of transport conditions on the stability of biochemical markers in blood. Clin Chem 1989; 35: 2313-2316